irl quarterly report€¦ · case study: jackie ensley, mls(ascp) cmsbb immunohematology reference...
TRANSCRIPT
![Page 1: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/1.jpg)
Case Study:
Jackie Ensley, MLS(ASCP)CMSBBCM
Immunohematology Reference Laboratory Manager
Kentucky Blood Center
1
![Page 2: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/2.jpg)
Objectives
1. To discuss a case study which required more complex antibody detection and identification
2. To review different methods of antibody detection
3. To discuss the transfusion recommendations and blood group involved with the case study
2
![Page 3: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/3.jpg)
3
![Page 4: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/4.jpg)
HOSPITAL RESULTS
• April 2017 patient reported to hospital with no defined
antibody pattern: 1+ reactions in gel No reactions in tube at AHG
Needs 2 units
4
![Page 5: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/5.jpg)
PATIENT HISTORY
• Female, 45 years old, Caucasian
• Last Transfusion in 2014
• History: B Positive -No blood bank history at any of the larger surrounding hospitals
-Previously had non-specific gel reactivity
- Hgb 6.2
-Patient diagnosis includes anemia and cellulitis left leg
5
![Page 6: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/6.jpg)
ABO/Rh performed
DAT Performed
Anti-A Anti-B Anti-D A1 Cell B Cell ABO/Rh
0 4+ 4+ 4+ 0 B Positive
Poly/tube Anti-IgG/ tube Anti-C3/ tube
0√ 0√ 0√
6
Reference Lab testing
![Page 7: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/7.jpg)
Reference Lab testing
Phenotyping
Be sure to rule out anti-f, -K, -Fyb, -Jkb, -Leb, -M, -s
7
Rh System Kell Duffy Kidd Lewis P MNS
D C c E e K Fya Fyb Jka Jkb Lea Leb P1 M N S s
+ + + + + 0 + 0 + 0 + 0 + 0 + + 0
Most likely R1R2
![Page 8: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/8.jpg)
Reference Lab Testing – Plasma
Rh System Kell Duffy Kidd Lewis P MNS Lutheran
IS
AH
G-P
eG
Cell
D C c E e V Cw K k Kpa Kpb Jsa Jsb Fya Fyb Jka Jkb Lea Leb P1 M N S s Lua Lub
I
+ + 0 0 + 0 0 + + 0 + 0 + + 0 + 0 0 + + 0 + + + 0 + 0 1+ II
+ 0 + + 0 0 0 0 + 0 + 0 + + + + + + 0 + + + + 0 0 + 0 0 AC
0 0
8
![Page 9: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/9.jpg)
Reference Lab Testing – Plasma
Rh System Kell Duffy Kidd Lewis P MNS
IS
AH
G-
Pe
G
Cell D C c E e K k Kpa Kpb Jsa Jsb Fya Fyb Jka Jkb Lea Leb P1 M N S s
1 0 0 + 0 + 0 + 0 + 0 + 0 0 + 0 0 + + 0 + 0 0 0 0
2 + + 0 0 + 0 + 0 + 0 + 0 + + 0 + 0 0 + + 0 + 0 0
3 0 0 + + 0 + 0 0 + 0 + 0 + 0 + + 0 0 0 + 0 + 0 0
4 0 0 + 0 + 0 + 0 + 0 + + 0 + 0 + 0 + + 0 0 + 0 0
5 + + 0 0 + + + 0 + 0 + + 0 0 + 0 + + 0 + 0 + 0 0
6 0 0 + 0 + 0 + 0 + 0 + + 0 + 0 0 + 0 + 0 + 0 0 0
Auto
+ + + + + 0 + 0 + 0 + 0 + 0 + + 0 0 0
9
![Page 10: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/10.jpg)
Reference Lab Testing – Plasma
10
Rh System Kell Duffy Kidd Lewis P MNS Lutheran
GEL
Cell D C c E e K k Kpa Kpb Jsa Jsb Fya Fyb Jka Jkb Lea Leb P1 M N S s Lua Lub
1 + + 0 0 + 0 + 0 + 0 + + + + 0 + 0 + + + + + 0 + 1+
2 + + 0 0 + 0 + 0 + 0 + + + 0 + 0 + + + 0 + 0 0 + 2+
3 + 0 + + 0 0 + 0 + 0 + 0 0 + 0 0 + + + 0 + + + + 3+
4 + 0 + 0 + 0 + 0 + 0 + 0 + + 0 0 0 + 0 + + + 0 + 1+
5 0 + + 0 + 0 + 0 + 0 + + + + + + 0 + + + + + 0 + 1+
6 0 0 + + + + + 0 + 0 + + 0 0 + 0 + 0 + 0 + + 0 + 3+
7 0 0 + 0 + + + 0 + 0 + 0 + + + + 0 0 + 0 0 + 0 + 3+
8 0 0 + 0 + 0 + 0 + 0 + 0 + 0 + 0 + + + 0 + + 0 + 2+
9 0 0 + 0 + 0 + 0 + 0 + + 0 + + 0 + 0 0 + 0 + 0 + 0
10 0 0 + 0 + 0 + 0 + 0 + 0 + + 0 0 0 + + 0 + 0 0 + 2+
11 + 0 + 0 + + + 0 + 0 + 0 + + + + 0 + + 0 + + 0 + 1+
Auto
+ + + + + 0 + 0 + 0 + 0 + 0 + + 0 0
![Page 11: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/11.jpg)
Reference Lab Testing – Plasma
Rh System Kell Duffy Kidd Lewis P MNS
AH
G-
Pe
G
GEL
Cell D C c E e K k Kpa Kpb Jsa Jsb Fya Fyb Jka Jkb Lea Leb P1 M N S s
1 0 0 + 0 + 0 + 0 + 0 + 0 0 + 0 0 + + 0 + 0 0 0 3+
2 + + 0 0 + 0 + 0 + 0 + 0 + + 0 + 0 0 + + 0 + 0 3+
3 0 0 + + 0 + 0 0 + 0 + 0 + 0 + + 0 0 0 + 0 + 0 3+
4 0 0 + 0 + 0 + 0 + 0 + + 0 + 0 + 0 + + 0 0 + 0 1+
5 + + 0 0 + + + 0 + 0 + + 0 0 + 0 + + 0 + 0 + 0 2+
6 0 0 + 0 + 0 + 0 + 0 + + 0 + 0 0 + 0 + 0 + 0 0 3+
Auto
+ + + + + 0 + 0 + 0 + 0 + 0 + + 0 0
11
Additional cells are tested in the gel and range from 1+ to 3+ as well
![Page 12: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/12.jpg)
• Let’s look at what we know:
Phase of reactivity: AHG
Strength/pattern of reactivity: almost all reactive, different strengths, weak in tube reacts best in gel
Patient history: previous history of non-specific gel reactivity
DAT/autocontrol: negative
Other info: B+
Serologic Problem Solving
So where do we go at this point?
12
![Page 13: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/13.jpg)
• Test phenotypically similar cell - negative for f, Fyb, Jkb, Leb, M, s
Positive
• Alloadsorption attempted
Unsuccessful
• Test with ficin treated cells
Negative
• Test with 0.2M DTT treated cells
Positive
Serologic Problem Solving
So where do we go at this point?
13
![Page 14: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/14.jpg)
Gerbich antibody
Chido/Rodgers antibody
14
Testing Results
Ficin / papain - Sensitive
DTT 0.2M - Resistant
Almost all cells reactive
Different reaction strengths
Does not adsorb out
Reacts best in gel, not very well in tube
![Page 15: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/15.jpg)
Pooled Plasma Inhibition
15
![Page 16: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/16.jpg)
Pooled Plasma Inhibition
16
Original plasma reactivity
Control plasma
reactivity (6% albumin)
Pooled plasma reactivity
1+ 1+ 0
1+ 1+ 0
![Page 17: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/17.jpg)
17
Great!
![Page 18: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/18.jpg)
18
Gotcha!
![Page 19: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/19.jpg)
19
![Page 20: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/20.jpg)
20
Anti-Ch
IgG Class
IAT Optimal
>90% Occurrence
FICIN SENSITIVE
DTT RESISTANT
![Page 21: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/21.jpg)
Chido/Rodgers Fun Fact: Named after the first antibody producers, Chido and Rodgers.
21 From Human Blood Groups by Geoff Daniels
![Page 22: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/22.jpg)
Chido/Rodgers - “HTLA”
• Reacts with majority of panel cells
• Frequently described as “reactive weakly by the antiglobulin test.” – Reactions are very weak and will break apart very
readily due to the weak attraction between the antigens and antibodies (low avidity).
– Repeated reactions may be irreproducible and not give the same strength or reactivity
• However, reactions of at least 1-2+ have also been seen using gel technique.
22
![Page 23: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/23.jpg)
Chido/Rodgers - “HTLA”
• These antibodies are not clinically significant
• Weak reactivity with high titers >64 are characteristic, but titers below 64 have also been seen.
**A high titer does not give us a specificity, but can help the lab determine if they are on the right track
with identification**
23
![Page 24: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/24.jpg)
Chido/Rodgers - “HTLA”
• Usually negative DAT, but each patient is different with unique history, diagnosis and treatment plans
• Reaction pattern suggests an antibody to a high-frequency antigen, and all or most cells are reactive at IgG.
• Reactions do not seem to fit a specific antibody or combination of antibodies pattern
24
![Page 25: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/25.jpg)
Chido/Rodgers - “HTLA”
• 1-2 phenotypically similar cells are run and are reactive
• Theoretically should not adsorb out of the plasma because of the low-avidity of the antibody
25
![Page 26: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/26.jpg)
Transfusions
• Antibody is not clinically significant
• Give compatible RBCs if able to but due to high prevalence of antigen may not be able to find crossmatch compatible
• May rarely see anaphylactic reactions with plasma products + platelets
26
![Page 27: IRL Quarterly Report€¦ · Case Study: Jackie Ensley, MLS(ASCP) CMSBB Immunohematology Reference Laboratory Manager Kentucky Blood Center 1 . Objectives 1. To discuss a case study](https://reader034.vdocuments.mx/reader034/viewer/2022051607/6036b7d74dabce6643789050/html5/thumbnails/27.jpg)
Resources
• Reid, Marion and Christine Lomas-Francis (2012). The Blood Group Antigen FactsBook, Elsevier.
• Daniels, G. (2013) Human Blood Groups, 3rd edition, Wiley-Blackwell, Oxford, UK.
Email me at [email protected]
27